Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.38 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | GRN | P28799 | 1/20 | 0.34 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.34 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16749901 | 1.00 | GABRR1 (0.44) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL5539684 | 1.00 | GABRR1 (0.44) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL22396499 | 0.97 | GABRR1 (0.42) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL25660349 | 0.81 | GABRR1 (0.42) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL4450853 | 0.81 | GABRR1 (0.42) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL13046473 | 0.80 | ACE2 (0.48) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL21133902 | 0.80 | GABRR1 (0.31) | GABRR1CYP1A2 | |
| SCHEMBL11564015 | 0.80 | CA1 (0.31) | — | |
| SCHEMBL10879775 | 0.79 | GABRR1 (0.46) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL4377120 | 0.79 | GABRR1 (0.41) | GABRR1CYP1A2TP53FOLH1NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1688476-B1 | LUBRICATING BASE OIL COMPOSITIONS | CHEVRON ORONITE CO (US) | 2019-07-03 | — | — | EP | claimed |
| US-20120219998-A1 | Producing a Trimethylpentanoic Acid Using Hybrid Polyketide Synthases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-08-30 | — | — | US | claimed |
| US-7465696-B2 | Lubricating base oil compositions and methods for improving fuel economy in an internal combustion engine using same | CHEVRON ORONITE COMPANY, LLC (US) | 2008-12-16 | — | — | US | claimed |
| EP-1688476-A1 | Lubricating base oil compositions and methods for improving fuel economy in an internal combustion engine using same | Chevron Oronite Company LLC (US) | 2006-08-09 | — | — | EP | claimed |
| US-20060172898-A1 | Lubricating base oil compositions and methods for improving fuel economy in an internal combustion engine using same | CHEVRON ORONITE COMPANY, LLC | 2006-08-03 | — | — | US | claimed |
| EP-4711434-A1 | REFRIGERANT CYCLE APPARATUS | Daikin Industries, Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4234293-B1 | REFRIGERATION CYCLE DEVICE FOR VEHICLE | DAIKIN IND LTD (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-12466805-B2 | Pharmaceutical compounds | ALMAC DISCOVERY LIMITED (GB) | 2025-11-11 | — | — | US | disclosed |
| US-12441922-B2 | Refrigerant-containing composition, use of same, refrigerator having same, operation method for said refrigerator, and refrigeration cycle device equipped with same | DAIKIN INDUSTRIES, LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| EP-4626984-A1 | PROCESS | Jotun A/S (NO) | 2025-10-08 | — | — | EP | disclosed |
| EP-4600314-A2 | FOULING RELEASE COATING COMPOSITION | Jotun A/S (NO) | 2025-08-13 | — | — | EP | disclosed |
| EP-4222223-B1 | FOULING RELEASE COATING COMPOSITION | JOTUN AS (NO) | 2025-07-02 | — | — | EP | disclosed |
| US-3998966-A | Anti-inflammatory, analgesic, anti-pyretic and anti-pruritic 6-substituted 2-naphthyl acetic acid derivative-containing compositions and methods of use thereof | SYNTEX CORPORATION (PM) | 1976-12-21 | — | — | US | disclosed |
| US-3980699-A | ANTIINFLAMMATORY, ANALGESICS, ANTIPYRETIC, ANTIPRURITIC | SYNTEX CORPORATION (PM) | 1976-09-14 | — | — | US | disclosed |
| US-3978124-A | ANALGESIC, ANTIPYRETIC | SYNTEX CORPORATION (PM) | 1976-08-31 | — | — | US | disclosed |
| US-3978116-A | ANALGESIC, ANTIPYRETIC | SYNTEX CORPORATION (PM) | 1976-08-31 | — | — | US | disclosed |
| US-3970684-A | Polyunsaturated prostaglandin derivatives | SYNTEX (U.S.A.) INC. (US) | 1976-07-20 | — | — | US | disclosed |
| US-3962275-A | ANTIGONADOTROPIC AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1976-06-08 | — | — | US | disclosed |
| US-3953470-A | Substituted prostaglandin derivatives | SYNTEX (U.S.A.) INC. (US) | 1976-04-27 | — | — | US | disclosed |
| US-3931297-A | 10-Hydroxy PGC compounds | SYNTEX (U.S.A.) INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466805-B2 | Pharmaceutical compounds | USP19, USP18, UBE2I | GABRR1 2775/4885CYP1A2 805/4885TP53 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.